New agents for Clostridium difficile-associated disease.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000627:therapeutic use*; D016360:Clostridioides difficile / Q000187:drug effects*; D004353:Drug Evaluation, Preclinical; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy*; D006801:Humans; D011355:Prodrugs / Q000737:chemistry / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D011355:Prodrugs